by admin | Jan 11, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Press Office – King’s College London – neurosciencenews.com Summary: Results of a phase three clinical trial of a novel brain cancer vaccine, DCVax-L, that uses a patient’s stem cells to target cancer cells extended survival by many months to years for...
by admin | Jan 10, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Elaine Fuchs – The Rockefeller University Image Caption: TGF beta signaling (red) is one way that the environment causes cancer stem cells at the stroma-tumor border (green) to become invasive. Living cells are dyed blue. Credit: Shaopeng Yuan What drives...
by admin | Jan 9, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Hayden E. Klein and Skylar Jeremias – AJMC Jana K. Dickter, MD, associate clinical professor, Division of Infectious Diseases, City of Hope, discusses a patient’s experience being the oldest person to successfully undergo a stem cell transplant while...
by admin | Jan 6, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Reference genomes used to direct the gene editor fail to account for human diversity By Jocelyn Kaiser – Science The 10-year-old gene-editing tool known as CRISPR is indispensable for engineering plants, tailoring lab animals, and probing basic biology. But...
by admin | Jan 5, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Toddler Thrives with Same Disease That Ended Siblings’ Lives By University of California San Francisco When Zahid and Sobia Bashir discovered their fetus had the same genetic disease that took the lives of two of their young children, they didn’t hesitate to sign up...
by admin | Jan 4, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Addresses major gap in effectiveness of immunotherapy Mount Sinai Press Release New York, NY – Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who...